Friday, March 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Funding News

Congressionally Directed Medical Research FY2014

by Global Biodefense Staff
March 10, 2014
CDMRP - Congressionally Directed Medical Research Programs

The Department of Defense office of Congressionally Directed Medical Research Programs (CDMRP) has detailed focus efforts and allocations for FY 2014 research projects. 

Comprehensive Program Announcements will be released during 2014. The Program Announcements will include detailed descriptions of funding mechanisms, evaluation criteria, submission requirements, and deadlines. Each Program Announcement may be downloaded from the Grants.gov website upon its release. 

The anticipated projects for FY2014 include:

  • Gulf War Illness Research Program – $20.0 million
  • Tuberous Sclerosis Complex Research Program – $6.0 million
  • Amyotrophic Lateral Sclerosis Research Program – $7.5 million
  • Autism Research Program – $6.0 million
  • Bone Marrow Failure Research Program – $3.2 million
  • Breast Cancer Research Program – $120.0 million
  • Duchenne Muscular Dystrophy Research Program – $3.2 million
  • Lung Cancer Research Program – $10.5 million
  • Multiple Sclerosis Research Program – $5.0 million
  • Neurofibromatosis Research Program – $15.0 million
  • Ovarian Cancer Research Program – $20.0 million
  • Peer Reviewed Cancer Research Program – $25.0 million
  • Peer Reviewed Medical Research Program – $200.0 million
  • Peer Reviewed Orthopaedic Research Program – $30.0 million
  • Prostate Cancer Research Program – $80.0 million
  • Spinal Cord Injury Research Program – $30.0 million

The CDMRP finds and funds the best research through a competitive, two-tier application review process to target innovative research approaches and encourage high-impact advancements.  The CDMRP maintains a disease-specific focus with funds directed toward most critical needs.

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
research team gathers in front of a window
CBRNE

UAMS Receives $3.4 Million to Study Radiation Injuries Caused by Nuclear Accidents and Bioterrorism

August 24, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC